Dr. Gregory Lubiniecki, vice president of oncology clinical research at Merck Research Laboratories, expressed optimism about the trial, citing antibody-drug conjugates as promising in cancer ...
Keytruda only uses the PD-1 pathway. Eliav Barr, chief medical officer at Merck Research Laboratories, said blocking both PD-1 and VEGF has proven tricky in the past. While the data are impressive ...
Dean Li, president of Merck Research Laboratories, told the meeting that cardiovascular disease is a big opportunity as it remains an epidemic, killing 35 million people during the pandemic while ...
Merck Research Laboratories, said in the release. “We continue to explore new ways to build upon our strong foundation in immuno-oncology and look forward to collaborating with the Epitopea team.” ...
president of Merck Research Laboratories, said: ““We are deeply grateful to the researchers and patients who participated in the anacetrapib clinical development programme, and in particular ...
Speaking on today's call will be Rob Davis, chairman and chief executive officer; Caroline Litchfield, chief financial officer; and Dr. Dean Li, president of Merck Research Labs. Before we get ...
Merck Research Laboratories. “This positive opinion is yet another testament to the clinical profile of CAPVAXIVE and brings us a step closer to helping protect adults in the EU against ...
Li, executive vice president and president, Merck Research Laboratories, are scheduled to participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Monday, March 3 ...
Merck Data at ACC.25 Highlight Innovative Advancements and Commitment to Improving Outcomes for People Living with Cardiovascular Disease ...
president of Merck Research Laboratories. MK-2578, in phase 2 trials, was Merck's most advanced biosimilar—similar to Amgen's blockbuster Aranesp (darbepoetin alfa). “Other biosimilars ...
Township officials have fielded a plan from Merck to modify two areas of wetlands on their West Point campus, changes that ...
President - Merck Research Laboratories; Merck & Co Inc Thank you for standing by. Welcome to the Merck and Company Q4 sales and earnings conference call. (Operator Instructions) This call is being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results